Items where Author is "Cross, A. K."

CROSS, A. K., HADDOCK, G., STOCK, C. J., ALLAN, S., SURR, J., BUNNING, R. A., BUTTLE, D. J. and WOODROOFE, N. (2006). ADAMTS -1 and -4 are up-regulated following transient middle cerebral artery occlusion in the rat and their expression is modulated by TNF in cultured astrocytes. Brain research, 1088 (1), 19-30.

CROSS, A. K., HADDOCK, G., SURR, J., PLUMB, J., BUTTLE, D. J. and WOODROOFE, N. (2005). Differential expression of ADAMTS -1, -4, -5 and TIMP -3 in rat spinal cord at different stages of acute experimental autoimmune encephalomyelitis. Journal of autoimmunity, 26 (1), 16-23.

REID, M. J., CROSS, A. K., HADDOCK, G., ALLAN, S. M., STOCK, C. J., WOODROOFE, M. N., BUTTLE, D. J. and BUNNING, R. A. D. (2009). ADAMTS-9 expression is up-regulated following transient middle cerebral artery occlusion (tMCAo) in the rat. Neuroscience letters, 452 (3), 252-257.

BRADFORD, C. M., CROSS, A. K., HADDOCK, G. and WOODROOFE, M. N. (2009). Citrullination in MS: potential for a new diagnostic test. British journal of neuroscience nursing, 5 (1), 1-13.

HADDOCK, G., CROSS, A. K., ALLAN, S., SHARRACK, B., CALLAGHAN, J. T., BUNNING, R. A., BUTTLE, D. J. and WOODROOFE, M. N. (2007). Brevican and phosphacan expression and localization following transient middle cerebral artery occlusion in the rat. Biochemical Society Transactions, 35 (4), p. 692.

HADDOCK, G., CROSS, A. K., PLUMB, J., SURR, J., BUTTLE, D. J., BUNNING, R. A. D. and WOODROOFE, M. N. (2005). Expression of ADAMTS-1, -4, -5 and TIMP-3 in normal and multiple sclerosis CNS white matter. Multiple Sclerosis, 12 (4), 386-396.

PLUMB, J., MCQUAID, S., CROSS, A. K., SURR, J., HADDOCK, G., BUNNING, R. A. D. and WOODROOFE, M. N. (2005). Upregulation of ADAM-17 expression in active lesions in multiple sclerosis. Multiple Sclerosis, 12 (4), 375-385.